From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

Predicting ACS in Patients with Troponin T Elevations

Clinical context is more important than troponin level when interpreting a positive test.

Troponin is detectable at very low levels, but a troponin "leak" does not always mean that an acute coronary syndrome (ACS) is present. To determine predictors of ACS in the presence of an abnormal troponin level, investigators studied 635 patients who had positive (>0.1 ng/mL) troponin tests during a 9-month period at two Israeli hospitals.

Two experts reviewed charts and retrospectively assigned a diagnosis of ACS (according to European Society of Cardiology/American College of Cardiology guidelines) to 53% of patients and a nonthrombotic cause to 41% (these patients had a definitive diagnosis of a condition known to cause troponin elevation, such as sepsis or pulmonary embolism). The diagnosis was unknown in 6%. Mean troponin T levels were 1.5 ng/mL in patients with ACS and 0.6 ng/mL in those with nonthrombotic causes.

The positive predictive value (PPV) of a positive troponin T test for the diagnosis of ACS was only 56% overall and 48% when the troponin level was between 0.1 and 1.0 ng/mL. In multivariate analysis, age, renal function, and troponin level were strongly associated with a diagnosis of ACS. In patients older than 70 with abnormal renal function, the PPV of a troponin level between 0.1 and 1.0 ng/mL was 27%. In patients of the same age with normal renal function and a troponin level greater than 1.0 ng/mL, the PPV was 90%. Inhospital mortality rates were nearly eight times higher in patients with nonthrombotic causes than in those with ACS.

Comment: This study addresses a common problem in the emergency department: the finding of a small troponin "leak" that seems not to be associated with ACS. Troponin elevation mandates admission, regardless of presumed cause, as even small elevations are associated with high mortality rates, and non-ACS elevation portends a worse prognosis than ACS elevation. Emergency physicians should never be persuaded to send patients home because "it’s just a troponin leak."

— J. Stephen Bohan, MD, MS, FACP, FACEP

Published in Journal Watch Emergency Medicine March 9, 2007

Citation(s):

Alcalai R et al. Acute coronary syndrome vs nonspecific troponin elevation: Clinical predictors and survival analysis. Arch Intern Med 2007 Feb 12; 167:276-81.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.